| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.
|
Science
|
1999
|
6.97
|
|
2
|
Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro.
|
Oncogene
|
2007
|
1.77
|
|
3
|
P-glycoproteins in pathology: the multidrug resistance gene family in humans.
|
Hum Pathol
|
1990
|
1.27
|
|
4
|
Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma.
|
Ann Surg
|
1988
|
1.19
|
|
5
|
Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer.
|
Oncogene
|
2010
|
1.11
|
|
6
|
Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.
|
Cancer Res
|
1986
|
1.02
|
|
7
|
Should flow cytometric DNA analysis precede definitive surgery for colon carcinoma?
|
Ann Surg
|
1985
|
1.02
|
|
8
|
Blood group precursor T-antigen expression in human urinary bladder carcinoma.
|
Am J Clin Pathol
|
1982
|
0.94
|
|
9
|
Flow cytometric analysis of paraffin-embedded tumors: implications for diagnostic pathology.
|
Hum Pathol
|
1986
|
0.94
|
|
10
|
Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis.
|
Clin Cancer Res
|
1997
|
0.94
|
|
11
|
Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry.
|
Exp Hematol
|
1995
|
0.93
|
|
12
|
Prognosis in carcinoma of the urinary bladder based upon tissue blood group abh and Thomsen-Friedenreich antigen status and karyotype of the initial tumor.
|
Cancer Res
|
1983
|
0.90
|
|
13
|
Blood group-related antigens as markers of malignant potential and heterogeneity in human carcinomas.
|
Hum Pathol
|
1986
|
0.89
|
|
14
|
Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity.
|
Arch Biochem Biophys
|
1995
|
0.88
|
|
15
|
Variable effects of sodium butyrate on the expression and function of the MDR1 (P-glycoprotein) gene in colon carcinoma cell lines.
|
Int J Cancer
|
1993
|
0.87
|
|
16
|
Abnormalities of molecular regulators of proliferation and apoptosis in carcinoma of the oral cavity and oropharynx.
|
Auris Nasus Larynx
|
2002
|
0.85
|
|
17
|
Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells.
|
Cancer Immunol Immunother
|
1993
|
0.85
|
|
18
|
Comparison of image analysis of imprints with flow cytometry for DNA analysis of solid tumors.
|
Mod Pathol
|
1989
|
0.85
|
|
19
|
Retrospective DNA analysis of head and neck squamous cell carcinoma.
|
Arch Otolaryngol Head Neck Surg
|
1986
|
0.84
|
|
20
|
Pathology of superficial bladder cancer with emphasis on carcinoma in situ.
|
Urology
|
1985
|
0.84
|
|
21
|
A multi-analyte serum test for the detection of non-small cell lung cancer.
|
Br J Cancer
|
2010
|
0.84
|
|
22
|
Variability in the expression of the O(H) antigen in human transitional epithelium.
|
J Urol
|
1981
|
0.84
|
|
23
|
Primary adenocarcinomas of the human urinary bladder: histochemical, immunological and ultrastructural studies.
|
Virchows Arch A Pathol Anat Histol
|
1981
|
0.84
|
|
24
|
Prognostic significance of p27 expression in carcinoma of the oral cavity and oropharynx.
|
Laryngoscope
|
1999
|
0.84
|
|
25
|
Accuracy of histone H3 messenger RNA in situ hybridization for the assessment of cell proliferation in human tissues.
|
Clin Cancer Res
|
1997
|
0.83
|
|
26
|
Detection of ABH tissue isoantigens by immunoperoxidase methods in normal and neoplastic urothelium. Comparison with the erythrocyte adherence method.
|
Am J Clin Pathol
|
1981
|
0.82
|
|
27
|
ERβ- and prostaglandin E2-regulated pathways integrate cell proliferation via Ras-like and estrogen-regulated growth inhibitor in endometriosis.
|
Mol Endocrinol
|
2014
|
0.82
|
|
28
|
Osteoporosis in women with eating disorders: comparison of physical parameters, exercise, and menstrual status with SPA and DPA evaluation.
|
J Nucl Med
|
1990
|
0.82
|
|
29
|
Prognostic significance of Bcl-2 and p53 expression in advanced laryngeal squamous cell carcinoma.
|
Head Neck
|
2001
|
0.81
|
|
30
|
Reversal of multi-drug resistance in vitro by fatty acid-PEG-fatty acid diesters.
|
Int J Cancer
|
1996
|
0.81
|
|
31
|
ABO blood type predicts the cytolocalization of anti-P-glycoprotein monoclonal antibody reactivity in human colon and ureter.
|
Hum Pathol
|
1990
|
0.81
|
|
32
|
Precision of DNA flow cytometry in inter-institutional analyses.
|
Cytometry
|
1991
|
0.81
|
|
33
|
Prognostic significance of Bcl-2 expression in localized squamous cell carcinoma of the head and neck.
|
Ann Otol Rhinol Laryngol
|
1997
|
0.80
|
|
34
|
Regulators of proliferation and apoptosis in carcinoma of the larynx.
|
Laryngoscope
|
1998
|
0.80
|
|
35
|
Origin of multiple "primary" colon carcinomas. A retrospective flow cytometric study.
|
Cancer
|
1986
|
0.80
|
|
36
|
Nucleolar organizer regions in squamous cell carcinoma of the head and neck.
|
Laryngoscope
|
1992
|
0.80
|
|
37
|
Comparison of solutol HS 15, Cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agents.
|
Int J Cancer
|
1995
|
0.79
|
|
38
|
Flow cytometric analysis of deparaffinized nuclei in urinary bladder carcinoma. Comparison with cytogenetic analysis.
|
Cancer
|
1986
|
0.79
|
|
39
|
Ethanol fixation of bladder irrigation specimens for flow cytometric analysis. A multiinstitutional study from the bladder cancer flow cytometry network.
|
Cancer
|
1989
|
0.78
|
|
40
|
Ligand-activated peroxisome proliferator-activated receptor β/δ modulates human endometrial cancer cell survival.
|
Horm Cancer
|
2013
|
0.78
|
|
41
|
Multiparameter flow cytometric analysis of colon polyps.
|
Am J Clin Pathol
|
1987
|
0.78
|
|
42
|
Tumor angiogenesis and p53 mutations: prognosis in head and neck cancer.
|
Arch Otolaryngol Head Neck Surg
|
1998
|
0.77
|
|
43
|
Activation of the LRP (lung resistance-related protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine.
|
Oncol Res
|
1998
|
0.77
|
|
44
|
Temperature alters lipopolysaccharide-induced cytokine secretion by RAW 264.7 cells.
|
Scand J Immunol
|
2003
|
0.77
|
|
45
|
Mutation of p53 in squamous cell cancer of the head and neck: relationship to tumor cell proliferation.
|
Laryngoscope
|
1997
|
0.77
|
|
46
|
Measurement variability in DNA flow cytometry of replicate samples.
|
Cytometry
|
1989
|
0.77
|
|
47
|
Proliferation of epithelia of noninvolved mucosa in patients with head and neck cancer.
|
Head Neck
|
1997
|
0.76
|
|
48
|
Correlation between ABO blood type and Golgi P-glycoprotein expression in epithelia.
|
Lancet
|
1990
|
0.76
|
|
49
|
Inhibition of cytarabine-induced MDR1 (P-glycoprotein) gene activation in human tumor cells by fatty acid-polyethylene glycol-fatty acid diesters, novel inhibitors of P-glycoprotein function.
|
Int J Cancer
|
1996
|
0.76
|
|
50
|
Flow cytometric analysis of heterogeneity in blood group-related antigen expression in a human urinary bladder carcinoma cell line, 647V.
|
Cancer Res
|
1985
|
0.76
|
|
51
|
Laboratory assessment of P-glycoprotein in cancer chemosensitivity testing.
|
Hum Pathol
|
1990
|
0.75
|
|
52
|
Induction of reversible changes in cell-surface glycoconjugates and lung colonization potential by 13-cis retinoic acid.
|
J Cell Biochem
|
1988
|
0.75
|
|
53
|
In vivo labelling with halogenated pyrimidines of squamous cell carcinomas and adjacent non-involved mucosa of head and neck region.
|
Cell Prolif
|
1995
|
0.75
|
|
54
|
Tissue blood group ABH and Thomsen-Friedenreich antigens in human urinary bladder carcinoma.
|
Prog Clin Biol Res
|
1984
|
0.75
|
|
55
|
Flow cytometry in melanoma.
|
Cancer Treat Res
|
1988
|
0.75
|
|
56
|
Variable expression of P-glycoprotein in normal, inflamed, and dysplastic areas in ulcerative colitis.
|
Dis Colon Rectum
|
1992
|
0.75
|
|
57
|
Continued malignant cell proliferation in head and neck tumors during cytotoxic therapy.
|
Clin Cancer Res
|
1996
|
0.75
|
|
58
|
A source of toxic gas leakage in a nuclear medicine department.
|
J Nucl Med
|
1991
|
0.75
|
|
59
|
Technology assessment of urinary flow cytometry.
|
Hum Pathol
|
1987
|
0.75
|
|
60
|
H, peanut lectin receptor, and carcinoembryonic antigen distribution in keratoacanthomas, squamous dysplasias, and carcinomas of skin.
|
J Dermatol Surg Oncol
|
1985
|
0.75
|
|
61
|
Expression of blood-group-related antigens in carcinoma in situ of the urinary bladder.
|
Cancer
|
1985
|
0.75
|
|
62
|
Surface charge distribution in normal and transformed rat bladder epithelial cells in vitro.
|
Lab Invest
|
1985
|
0.75
|
|
63
|
Blood group antigens in tumor cell membranes.
|
Biomembranes
|
1983
|
0.75
|
|
64
|
PCR production of a digoxigenin-labeled probe for the detection of human cytomegalovirus in tissue sections.
|
Diagn Mol Pathol
|
1994
|
0.75
|
|
65
|
Natural killer cell cytotoxicity and the multidrug resistance gene.
|
Transplant Proc
|
1993
|
0.75
|
|
66
|
Bone densitometry of osteopetrosis in an adolescent girl.
|
Clin Nucl Med
|
1990
|
0.75
|
|
67
|
Inverted papilloma of the urinary bladder: ultrastructural and immunologic studies.
|
Cancer
|
1980
|
0.75
|
|
68
|
The prognostic value of DNA ploidy combined with histologic substaging for incidental carcinoma of the prostate gland.
|
Am J Clin Pathol
|
1988
|
0.75
|
|
69
|
Modulation of the metastatic phenotype by 13-cis-retinoic acid.
|
J Natl Cancer Inst
|
1987
|
0.75
|
|
70
|
Comparison of automated and manual techniques for analysis of DNA frequency distributions in bladder washings.
|
Cytometry
|
1988
|
0.75
|
|
71
|
Blood group antigens and ploidy as prognostic factors in urinary bladder carcinoma.
|
Monogr Pathol
|
1986
|
0.75
|